Skip to main content

Peer Review reports

From: Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial

Original Submission
28 Jan 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
14 May 2016 Editorially accepted
28 May 2016 Article published 10.1186/s12872-016-0289-0

You can find further information about peer review here.

Back to article page